1,602 hedge funds and large institutions have $108B invested in Amgen in 2017 Q3 according to their latest regulatory filings, with 93 funds opening new positions, 611 increasing their positions, 643 reducing their positions, and 66 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding in top 10

Funds holding in top 10:

more funds holding

Funds holding:

0.54% more ownership

Funds ownership: 78.5%79.03% (+0.54%)

5% less call options, than puts

Call options by funds: $1.3B | Put options by funds: $1.36B

5% less repeat investments, than reductions

Existing positions increased: 611 | Existing positions reduced: 643

Holders
1,602
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
88
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.3B
Puts
$1.36B
Net Calls
Net Calls Change

Top Buyers

1 +$380M
2 +$260M
3 +$259M
4
Goldman Sachs
Goldman Sachs
New York
+$185M
5
PI
Putnam Investments
Massachusetts
+$158M

Top Sellers

1 -$394M
2 -$236M
3 -$206M
4
Flossbach Von Storch
Flossbach Von Storch
Germany
-$181M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$162M
Name Holding Trade Value Shares
Change
Change in
Stake
76
$180M
77
$180M
78
$172M
79
$171M
80
$158M
81
$152M
82
$152M
83
$142M
84
$138M
85
$138M
86
$137M
87
$135M
88
$133M
89
$133M
90
$133M
91
$132M
92
$132M
93
$131M
94
$126M
95
$122M
96
$121M
97
$121M
98
$120M
99
$117M
100
$117M